0001127602-20-019382.txt : 20200610
0001127602-20-019382.hdr.sgml : 20200610
20200610180439
ACCESSION NUMBER: 0001127602-20-019382
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200610
DATE AS OF CHANGE: 20200610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldstein Dan
CENTRAL INDEX KEY: 0001722327
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 20955682
MAIL ADDRESS:
STREET 1: HAEMONETICS CORPORATION
STREET 2: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0328
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-06-08
0000313143
HAEMONETICS CORP
HAE
0001722327
Goldstein Dan
125 SUMMER STREET
BOSTON
MA
02110
1
VP, Corporate Controller
Common Stock
2020-06-08
4
S
0
83
97.03
D
2170
D
Common Stock
2020-06-08
4
M
0
1106
41.64
A
3276
D
Common Stock
2020-06-08
4
S
0
1106
99.09
D
2170
D
Common Stock
2020-06-09
4
S
0
187
97.19
D
1983
D
Non-qualified Stock Option (Right to Buy)
41.64
2020-06-08
4
M
0
1106
0
D
2020-06-06
2024-06-06
Common Stock
1106
1107
D
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
This number includes unvested RSUs previously reported.
Transaction pursuant to an existing 10b5-1 trading plan.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
/s/ Thomas V. Powers, attorney-in-fact for Mr. Goldstein
2020-06-10